Pediatric Use of Antipsychotics Linked to Metabolic and Cardiovascular Events

Over the last 10 years we have seen a huge increase in the use of antipsychotic medication for our children, despite adequate safety studies (if your autistic child is on any antipsychotic drug other than Risperdal, they are being used off-label and not approved). Many physicians are blindly prescribing these medications without proper training or even monitoring the child for side effects.

Omalizumab (Xolair) linked to Cardiovascular Adverse Events

The popular asthma medication Xolair ,used in patients with moderate to severe asthma , was recently associated with adverse cardiovascular adverse events from the ongoing interim safety study entitled “Evaluating the Clinical Effectiveness and Long Term Safety in Patients with Moderate to Severe Asthma (EXCELS).”